Navigation Links
Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
Date:12/14/2007

eform Act of 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA(R) (Human TGFbeta3) and GA-GCB (velaglucerase alfa); manufacturing and commercialization including, but not limited to, the launch and establishment in the market of VYVANSE(TM)(lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products including, but not limited to, the impact of those on Shire's ADHD franchise; patents including, but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval including, but not limited to, the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, particularly Shire plc's Annual Report on Form 10-K for the year ended December 31, 2006.

(1) Source: Rewers, Gastroenterology vol128, 2005


'/>"/>
SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. ATS Medical Expands Open Pivot Heart Valve Offerings
9. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
10. BioLife Solutions Expands Scientific Advisory Board
11. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Researchers from the National Institute of Standards and ... have demonstrated a new design for an atomic ... comb, or a microcomb. , The microcomb clock, ... of the new journal Optica ,* is ... microcomb, and its accurate conversion of optical frequencies ...
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and distributor ... other markets, announced today that it has closed on ... investors led by Novit L.P., an investment arm of ... the signing of a Securities Purchase Agreement under which ... a price per share of $1.00, resulting in a ...
(Date:7/22/2014)... 22, 2014 OHAUS Corporation, a ... mechanical balances and scales, proudly announces its Explorer ... Laboratory Equipment magazine’s 2014 “Readers' Choice” Award for ... year the Explorer was voted the best laboratory ... Choice Awards celebrates “excellence in product design and ...
(Date:7/22/2014)... SHENZHEN, China , July 22, 2014 ... Tech), a subsidiary of BGI, the world,s largest ... a new human whole exome sequencing service based ... service includes in-depth bioinformatics analysis and SNP validation, ... 31, 2014. Complete Genomics, highly ...
Breaking Biology Technology:'Comb on a chip' powers new NIST/Caltech atomic clock design 2CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3
... the Albert Einstein College of Medicine of Yeshiva University ... can cure hemophilia A (the most common form of ... online February 14 in the Journal of Clinical Investigation. ... is characterized by recurrent, spontaneous bleeding that can cause ...
... at the University of Illinois helped lead a ... strategy for serious Staphylococcus aureus (Staph) infections. The ... version of Science magazine, comes at a time ... for methicillin-resistant S. aureus) are spreading in epidemic ...
... Hospital(R), the premier pediatric research and treatment center, can ... ... More than 60,000 callers,generated $6.1 million dollars during the ... a division of Univision,Communications Inc. The radiothon, benefiting St. Jude ...
Cached Biology Technology:Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report 2New approach may render disease-causing staph harmless 2New approach may render disease-causing staph harmless 3More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 2More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 3
(Date:7/22/2014)... have adapted to New York City,s human behaviour, allowing ... than their fellow squirrels in the woods. , Dr ... & Agriculture, led the study that proved eastern grey ... environments and prevent unnecessary responses when humans acted in ... , "As we rapidly increase the spread of ...
(Date:7/22/2014)... Playing in schoolyards that feature natural habitats and trees ... stress and inattention, according to a University of Colorado ... in such settings also provide stress-reducing benefits for youth, ... Health & Place. The study is one of ... relationship between student access to green settings and stress. ...
(Date:7/22/2014)... box and you,re likely to find that the lunches and ... findings of a study conducted by researchers at the Friedman ... in the Department of Public Health and Community Medicine at ... online ahead of print in the Journal of the ... senior author Jeanne Goldberg, Ph.D., R.D., a professor at the ...
Breaking Biology News(10 mins):New York squirrels are nuts about city life 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3Room for improvement in elementary school children's lunches and snacks from home 2
... will host its largest ever annual meeting next week ... diagnostic professionals plus 1,300 representatives from more than 180 ... sessions and 350 poster presentations, the AMP 2013 Annual ... all things molecular. The event, to be held November ...
... membrane-crossing pores, using Lego-like DNA building blocks, has been developed ... University of Cambridge and the University of Southampton. ... synthetic biology and the technique has potential applications in diagnostic ... current issue of the journal Angewandte Chemie . ...
... Mass. (November 4, 2013) Whitehead Institute scientists report ... known as Birt-Hogg-Dub cancer syndrome also prevents activation of ... This is an unexpected finding, as ... their unchecked growth and expansion. In the case of ...
Cached Biology News:The Association for Molecular Pathology announces highlights of Phoenix meeting 2Designer piercings: New membrane pores with DNA nanotechnology 2Designer piercings: New membrane pores with DNA nanotechnology 3Gene responsible for hereditary cancer syndrome found to disrupt critical growth-regulating pathway 2
HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry....
...
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry....
Biology Products: